Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades
Alimentary Pharmacology & Therapeutics · 2024-03 · 59 (5) · 656-665
DOI: 10.1111/apt.17836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 19.12.2023. Verfasst von Lorant Gonczi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ÚNKP-23-4-II-SE-20 New National Excellence Program of the Ministry for Culture and Innovation, Source of the National Research, Development and Innovation Fund.
Abstract (Originalsprache)
Background
Few population‐based studies have investigated the prevalence and disease course of perianal manifestation in Crohn's disease.
Aims
To analyse the prevalence and outcomes of perianal Crohn's disease including medical therapies and need for perianal surgery, over different therapeutic eras based on the time of diagnosis; cohort A (1977–1995), cohort B (1996–2008), and cohort C (2009–2018)
Methods
Patient inclusion lasted between 1977 and 2018. We followed patients prospectively, and regularly reviewed both in‐hospital and outpatient records. We defined a perianal surgical procedure as any perianal incision and excision, fistulotomy, or abscess drainage.
Results
We included 946 incident patients. Perianal disease at diagnosis was present in 17.4% ( n = 165) of the total cohort, with a declining prevalence in cohorts A/B/C, respectively (24.7%/18.5%/13.2%; p = 0.001). By the end of follow‐up, an additional 9.3% ( n = 88) of the total cohort developed perianal disease. Cumulative immunosuppressive and biologic exposure increased over time; biologic use was higher in patients with perianal disease [ p Log Rank < 0.001]. The overall rate of perianal surgery was 44.7% (113/253), with a probability of 28.3% (95% CI: 25.4–31.2) after 10 years, 41.0% (95% CI: 37.5–44.5) after 20 years, and 64.1% (95% CI: 59–69.2) after 30 years. There was no statistically significant difference in the probability of first perianal surgery among cohorts A/B/C [Log Rank = 0.594].
Conclusions
The burden of perianal disease and perianal surgery rates were high in this cohort. Therapeutic strategy was accelerated in patients with perianal Crohn's over time with higher exposure to immunosuppressives and biologics. Surgical management of perianal disease remained unchanged amongst the cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
- Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary.
- Department of Gastroenterology, Hungarian Defence Forces Medical Centre, Budapest, Hungary.
- Department of Gastroenterology, Grof Eszterhazy Hospital, Papa, Hungary.
- Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada.
ORCID-Profile: Peter L Lakatos
Förderung
- ÚNKP-23-4-II-SE-20 New National Excellence Program of the Ministry for Culture and Innovation
- Source of the National Research, Development and Innovation Fund
Zitieren
APA
Gonczi, L., Lakatos, L., Golovics, P. A., Angyal, D., Balogh, F., Ilias, A., Pandur, T., David, G., Erdelyi, Z., Szita, I., & Lakatos, P. L. (2024). Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades. Alimentary Pharmacology & Therapeutics, 59(5), 656-665. https://doi.org/10.1111/apt.17836
Vancouver
Gonczi L, Lakatos L, Golovics PA, Angyal D, Balogh F, Ilias A, et al. Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades. Alimentary Pharmacology & Therapeutics. 2024;59(5):656-665. doi:10.1111/apt.17836
BibTeX
@article{Gonczi2024,
author = {Gonczi, Lorant and Lakatos, Laszlo and Golovics, Petra A and Angyal, Dorottya and Balogh, Fruzsina and Ilias, Akos and Pandur, Tunde and David, Gyula and Erdelyi, Zsuzsanna and Szita, Istvan and Lakatos, Peter L},
title = {Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
volume = {59},
number = {5},
pages = {656--665},
doi = {10.1111/apt.17836}
}
EUVIMED